期刊
FEBS JOURNAL
卷 288, 期 6, 页码 1956-1974出版社
WILEY
DOI: 10.1111/febs.15561
关键词
4-nitrobenzoate; cholesterol content; coenzyme Q deficiency; coq2 inhibition; HIF-1 alpha; respiratory chain
资金
- China Scholarship Council (CSC)
- Fondazione Veronesi Research Fellowship 2019
Inhibition of coq2 by the competitive inhibitor 4-NB reduces cellular CoQ content, impairs mitochondrial function, increases cholesterol levels, and disrupts plasma membrane properties. However, 4-NB treatment has minimal impact on cell viability, as cells adapt to glycolysis for metabolic rewiring.
Coenzyme Q(10)(CoQ, ubiquinone) is a redox-active lipid endogenously synthesized by the cells. The final stage of CoQ biosynthesis is performed at the mitochondrial level by the 'complex Q', where coq2 is responsible for the prenylation of the benzoquinone ring of the molecule. We report that the competitive coq2 inhibitor 4-nitrobenzoate (4-NB) decreased the cellular CoQ content and caused severe impairment of mitochondrial function in the T67 human glioma cell line. In parallel with the reduction in CoQ biosynthesis, the cholesterol level increased, leading to significant perturbation of the plasma membrane physicochemical properties. We show that 4-NB treatment did not significantly affect the cell viability, because of an adaptive metabolic rewiring toward glycolysis. Hypoxia-inducible factor 1 alpha (HIF-1 alpha) stabilization was detected in 4-NB-treated cells, possibly due to the contribution of both reduction in intracellular oxygen tension and ROS overproduction. Exogenous CoQ supplementation partially recovered cholesterol content, HIF-1 alpha degradation, and ROS production, whereas only weakly improved the bioenergetic impairment induced by the CoQ depletion. Our data provide new insights on the effect of CoQ depletion and contribute to shed light on the pathogenic mechanisms of ubiquinone deficiency syndrome.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据